Matches in Wikidata for { <http://www.wikidata.org/entity/Q65390682> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q65390682 description "assaig clínic" @default.
- Q65390682 description "clinical trial" @default.
- Q65390682 description "clinical trial" @default.
- Q65390682 description "clinical trial" @default.
- Q65390682 description "clinical trial" @default.
- Q65390682 description "ensaio clínico" @default.
- Q65390682 description "ensayo clínico" @default.
- Q65390682 description "ensayu clínicu" @default.
- Q65390682 description "essai clinique" @default.
- Q65390682 description "klinisch onderzoek" @default.
- Q65390682 description "клінічне випробування" @default.
- Q65390682 name "Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients" @default.
- Q65390682 name "Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients" @default.
- Q65390682 type Item @default.
- Q65390682 label "Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients" @default.
- Q65390682 label "Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients" @default.
- Q65390682 prefLabel "Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients" @default.
- Q65390682 prefLabel "Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients" @default.
- Q65390682 P1132 Q65390682-7564DB46-67A3-4D42-BA73-83EB54BA1457 @default.
- Q65390682 P1476 Q65390682-14A367D4-8743-4F9F-8BB5-0E8C9CB218DD @default.
- Q65390682 P17 Q65390682-51BCFC3B-B4BF-47D0-9B56-4DAE7853AB40 @default.
- Q65390682 P17 Q65390682-873CE5A1-38DB-4C2A-BF07-5B8176091495 @default.
- Q65390682 P2899 Q65390682-F539C2F2-F9BC-4D04-9F11-029C0805D822 @default.
- Q65390682 P3098 Q65390682-537AEF4F-F4EA-4F65-9723-EE9B699042EB @default.
- Q65390682 P31 Q65390682-27499243-3DDD-4468-B07C-BCF06E0350FE @default.
- Q65390682 P4135 Q65390682-DAD1C509-C84D-45E9-A508-2AA3B701CF74 @default.
- Q65390682 P4844 Q65390682-F1940E01-6E46-499D-85CC-06AAAF6793B9 @default.
- Q65390682 P580 Q65390682-87D98462-DA9D-4305-AD48-DD6170D6A14F @default.
- Q65390682 P582 Q65390682-6B72135B-7C82-45AA-BE1E-D1D01B005841 @default.
- Q65390682 P6099 Q65390682-AAA6427D-D2E0-4CAC-82FE-867F5CFE1992 @default.
- Q65390682 P6153 Q65390682-33195FD3-B403-462B-8E43-207161FDDBFC @default.
- Q65390682 P6153 Q65390682-8514E7B5-F077-43FF-9D61-DB74A81FA3A5 @default.
- Q65390682 P6153 Q65390682-AA917F49-B064-4F16-AA94-E434B29D7006 @default.
- Q65390682 P8363 Q65390682-6226ACEA-D261-4CCF-A646-12D390296F2C @default.
- Q65390682 P1132 "+126" @default.
- Q65390682 P1476 "Multicentre, Open Label, Prospective, Randomised Clinical Trial to Evaluate the Effectiveness of Abacavir 600 mg+ Lamivudine 300 mg as QD+ Efavirenz 600 mg QD Versus Kaletra 400/100 mg BID as Initial Antiretroviral Treatment" @default.
- Q65390682 P17 Q29 @default.
- Q65390682 P17 Q38 @default.
- Q65390682 P2899 "+18" @default.
- Q65390682 P3098 "NCT00318123" @default.
- Q65390682 P31 Q30612 @default.
- Q65390682 P4135 "+80" @default.
- Q65390682 P4844 Q304330 @default.
- Q65390682 P580 "2004-04-01T00:00:00Z" @default.
- Q65390682 P582 "2007-04-01T00:00:00Z" @default.
- Q65390682 P6099 Q42824827 @default.
- Q65390682 P6153 Q20901245 @default.
- Q65390682 P6153 Q5902953 @default.
- Q65390682 P6153 Q5908655 @default.
- Q65390682 P8363 Q78089383 @default.